Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ASEP Medical Holdings (FRA:JJ80) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
ASEP Medical Holdings EBITDA Margin % Related Terms
ASEP Medical Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for ASEP Medical Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:JJ80 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison
For the Biotechnology subindustry, ASEP Medical Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASEP Medical Holdings EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where ASEP Medical Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASEP Medical Holdings (FRA:JJ80) has a EBITDA Margin % of -243.48% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ASEP Medical Holdings and its competitors. According to the industry distribution chart, ASEP Medical Holdings ranks #792 out of 940 companies in the Biotechnology industry, placing it in the top 84.3%.
Is ASEP Medical Holdings' EBITDA Margin % too high?
ASEP Medical Holdings' current EBITDA Margin % is -243.48%. Based on the distribution chart, ASEP Medical Holdings ranks #792 out of 940 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, ASEP Medical Holdings has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ASEP Medical Holdings ranks #792 out of 940 companies for EBITDA Margin %. This places ASEP Medical Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ASEP Medical Holdings and its competitors. ASEP Medical Holdings's current EBITDA Margin % is -243.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (FRA:JJ80) has a current EBITDA Margin % of -243.48%. The current EBITDA Margin % is -243.48%. ASEP Medical Holdings' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For ASEP Medical Holdings (FRA:JJ80), the current EBITDA Margin % is -243.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
31GF Score
Get the complete analysis for FRA:JJ80
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:JJ80 has been successfully added to your 
